You have 9 free searches left this month | for more free features.

City

Changchun (1)

Chendu (1)

Condition

Advanced Solid Tumor (1)

Esophageal Cancer (1)

Healthy Volunteers (1)

Overall Status

Active, not recruiting (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Sunshine Lake Pharma Co., Ltd. (2)

Collaborator

Intervention

larotinib (2)

itraconazole (1)

rifampin (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

larotinib

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Esophageal Cancer, Advanced Solid Tumor Trial in Chendu (Larotinib)

Not yet recruiting

Esophageal Cancer
Advanced Solid Tumor

Larotinib

Chendu, Sichuan, China

West China Hospital of Sichuan University

May 4, 2022

Healthy Volunteers Trial in Changchun (Larotinib, Rifampin, Itraconazole)

Active, not recruiting

Healthy Volunteers

Larotinib
+2 more

Changchun, Jilin, China

First Hospital of Jilin University

Oct 26, 2022